N/A N=92 Health Services Research

Early Community Client-LED ART Delivery in Nakivale Refugee Settlement

HIV Seropositivity

Bottom Line

View on ClinicalTrials.gov: NCT04736316 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jul 2023

Primary outcome: Primary: Number of Participants in HIV Care (Linkage) Among the Early CCLAD Participants — 31 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Early CCLAD (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: University of Washington
Primary completion: Mar 2022

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Participants in HIV Care (Linkage) Among the Early CCLAD Participants	31	—
PRIMARY Number of Early CCLAD Group Visits Attended (Retention) Among Early CCLAD Participants	3.3	—
PRIMARY ART Initiation	31	—
PRIMARY Clinical Outcomes: Number of Participants With Viral Suppression	20; 3; 8	—
PRIMARY Total Number of Clinic Visits Per Participant (Incl. CCLAD Visits)	5.1	—
PRIMARY Survey Score Related to Psychosocial Factors: Perceived Health	11; 10; 5; 16	—
PRIMARY Survey Score Related Factors: Screened Positive for Depression	10; 4	—
PRIMARY Survey Score Related Factors: Screened Positive for Anxiety	9; 6	—
PRIMARY Survey Score Related Factors: Screening Positive for PTSD	12; 9	—
PRIMARY Survey Score Related Factors: Screening Positive for Low of Social Support	4; 2	—

Summary

To pilot early community client-led ART (anti-retroviral therapy) delivery (CCLAD) in Nakivale Refugee Settlement in Uganda and assess the feasibility and acceptability of this intervention in this setting.

Eligibility Criteria

Inclusion Criteria

Adults ≥ 18 years of age who present to the Nakivale Health Center and agree/consent to test for HIV.

Exclusion Criteria

Unable to understand one of the study languages (English, Kinyarwanda, Kiswahili, Runyankore).
Subjects who do not test positive for HIV at health center will not be eligible to participate in the early community-based client-led antiretroviral therapy delivery intervention

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04736316). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.